tech
January 1, 2026
The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump
Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology uncertain and up for grabs
TL;DR
- The development of mRNA vaccines for COVID-19 highlighted the potential for accelerated scientific breakthroughs when traditional constraints are relaxed.
- Despite initial success and significant US investment, federal funding for mRNA research is being cut, and regulatory approaches are becoming uncertain under the current administration.
- These policy changes are making the US an unreliable partner, potentially damaging public confidence and hindering the development and adoption of mRNA therapies.
- The EU and UK are positioned to potentially take the lead in mRNA research and manufacturing, with initiatives already underway to attract scientists and invest in the technology.
- The future of mRNA applications, including vaccines for flu, HIV, and cancer, depends on sustained funding and predictable regulation, which is currently lacking in the US.
Continue reading the original article